Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00285233 · ClinicalTrials.gov registry record · Phase 1

Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes

A Phase 1 study, sponsored by University of Minnesota.

Completed
Registry status
Phase 1
Development phase
8
Enrollment target

NCT00285233: Completed Phase 1 study, sponsored by University of Minnesota.

NCT00285233 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00285233, a Phase 1 study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
Phase 1
Development phase
8 participants
Enrollment target

Study Summary

The objective of this study is to assess the safety and efficacy of islet allotransplantation for the reestablishment of stable glycemic control in patients with type 1 diabetes, using anti-thymocyte globulin induction immunosuppression with sirolimus, mycophenolate mofetil and low dose tacrolimus maintenance immunosuppression.

Interventions

  • BIOLOGICAL Allogeneic islets of Langerhans transplant

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2000-09
Est. Completion 2005-03
Phase Phase 1
University of Minnesota

966 total trials

What the finished NCT00285233 record still lists

NCT00285233 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which Allogeneic islets of Langerhans transplant is the first listed.

NCT00285233 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00285233 about?

NCT00285233 is a clinical study titled "Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes". The objective of this study is to assess the safety and efficacy of islet allotransplantation for the reestablishment of stable glycemic control in patients with type 1 diabetes, using anti-thymocyte globulin induction immunosuppression with sirolimus, mycophenolate mofetil and low dose tacrolimus m...

What is the current status of trial NCT00285233?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2000-09. Estimated completion is 2005-03.

What interventions are being tested in trial NCT00285233?

The interventions under investigation include: Allogeneic islets of Langerhans transplant (BIOLOGICAL).

Who is sponsoring clinical trial NCT00285233?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00285233's enrollment target sits among peer trials

8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00285233, the US trial registry maintained by the National Library of Medicine. NCT00285233 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.